Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, ...

Cheryl Allen, BS Pharm, MBA, founding partner, Curatio Scientia Advisors, hopes to use the conference to explore how ...

Point-of-care engagement is essential for converting investments in payer negotiations and copay programs into prescriptions.

Cheryl Allen, BS Pharm, MBA, founding partner, Curatio Scientia Advisors, discusses how the convergence of patient access ...

That era is ending. Policy reform, economic pressure, and patient empowerment have fractured that reality into three distinct ...

This shift in data analysis enables what can be called a “precision medical affairs” approach. Instead of a one-size-fits-all ...

In today’s Pharma Pulse, the University of Maryland expands its medical class to combat physician shortages and much more.

In today’s Pharma Pulse, Augmentin XR is the first drug approved under the FDA's new CNPV pilot program and much more.

Counterfeit pharma networks are becoming more sophisticated—leveraging advanced packaging, fragmented logistics, and global trade gaps—making detection harder and patient risk greater than ever. “Now ...

The 20th installment of Trade & Channel Strategies carried on with a focus on boosting access to medication.

Rising OOP costs are a barrier to healthcare, with many insured adults spending over $1,000 annually on these expenses. Prescription medication and insurance premiums are top affordability concerns, ...